8 hours Ago By ABMN Staff
Elevance Health, Inc. ( NYSE:ELV – Free Report ) – Investment analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Elevance Health in a research report issued on Wednesday, April 23rd. Cantor Fitzgerald analyst S.
James now forecasts that the company will post earnings per share of $34.47 for the year, down from their previous forecast of $34.57.
Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $33.
96 per share. Elevance Health ( NYSE:ELV – Get Free Report ) last posted its quarterly earnings data on Tuesday, April 22nd. The company reported $11.
97 earnings per share for the quarter, topping the consensus estimate of $10.60 by $1.37.
The business had revenue of $48.77 billion during the quarter, compared to analysts’ expectations of $46.26 billion.
Elevance Health had a return on equity of 18.28% and a net margin of 3.38%.
View Our Latest Stock Analysis on ELV Elevance Health Stock Up 0.5 % Shares of ELV stock opened at $429.08 on Thursday.
Elevance Health has a 12 month low of $362.21 and a 12 month high of $567.26.
The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.
71. The firm has a market cap of $97.14 billion, a PE ratio of 16.
75, a price-to-earnings-growth ratio of 1.18 and a beta of 0.77.
The stock has a 50 day moving average of $419.22 and a 200-day moving average of $408.94.
Institutional Trading of Elevance Health Hedge funds have recently modified their holdings of the stock. Virtu Financial LLC acquired a new stake in shares of Elevance Health in the 3rd quarter valued at $2,828,000. Te Ahumairangi Investment Management Ltd increased its position in Elevance Health by 39.
6% in the third quarter. Te Ahumairangi Investment Management Ltd now owns 10,508 shares of the company’s stock worth $5,433,000 after purchasing an additional 2,983 shares during the period. Tudor Financial Inc.
bought a new stake in Elevance Health during the 3rd quarter worth about $235,000. Anchor Investment Management LLC lifted its position in Elevance Health by 22.9% during the 3rd quarter.
Anchor Investment Management LLC now owns 6,098 shares of the company’s stock valued at $3,171,000 after purchasing an additional 1,135 shares during the period. Finally, World Investment Advisors LLC bought a new position in shares of Elevance Health in the 3rd quarter valued at about $8,855,000. 89.
24% of the stock is owned by institutional investors. Insider Buying and Selling at Elevance Health In related news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the company’s stock in a transaction dated Wednesday, March 5th.
The shares were sold at an average price of $396.30, for a total transaction of $1,388,635.20.
Following the transaction, the executive vice president now owns 10,116 shares in the company, valued at $4,008,970.80. This represents a 25.
73 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website . Also, CAO Ronald W.
Penczek sold 443 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $415.13, for a total transaction of $183,902.
59. Following the completion of the sale, the chief accounting officer now owns 1,847 shares of the company’s stock, valued at $766,745.11.
The trade was a 19.34 % decrease in their position. The disclosure for this sale can be found here .
Company insiders own 0.29% of the company’s stock. Elevance Health Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th.
Investors of record on Tuesday, June 10th will be issued a dividend of $1.71 per share. This represents a $6.
84 annualized dividend and a yield of 1.59%. The ex-dividend date is Tuesday, June 10th.
Elevance Health’s dividend payout ratio is currently 26.71%. Elevance Health Company Profile ( Get Free Report ) Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States.
The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. See Also Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.
com's FREE daily email newsletter ..
